UCLA Health is set to begin a multi-site pilot study to explore whether a ketogenic diet, when combined with mood stabilizing medications, helps stabilize mood symptoms in teenagers and young adults who have bipolar disorder.
Read more here!
April 1, 2024
Peer-reviewed clinical pilot trial reports dramatic improvements in psychiatric and metabolic outcomes in bipolar disorder and schizophrenia
Read more
SAN MATEO, Calif.–(BUSINESS WIRE)–Baszucki Group today announced a partnership with University of Maryland School of Medicine for an innovative training initiative that will build capacity for delivering ketogenic...
Read more
ACCORD is proud to announce that the Baszucki Group has awarded more than $600,000 in research funding to support a groundbreaking study on metabolic psychiatry in partnership with...
Read more